103 related articles for article (PubMed ID: 26239567)
1. Plasma EGFR Mutation Detection Associated With Survival Outcomes in Advanced-Stage Lung Cancer.
Lam DC; Tam TC; Lau KM; Wong WM; Hui CK; Lam JC; Wang JK; Lui MM; Ho JC; Ip MS
Clin Lung Cancer; 2015 Nov; 16(6):507-13. PubMed ID: 26239567
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors for Survival After Recurrence in Patients With Completely Resected Lung Adenocarcinoma: Important Roles of Epidermal Growth Factor Receptor Mutation Status and the Current Staging System.
Kudo Y; Shimada Y; Saji H; Kato Y; Yoshida K; Matsubayashi J; Nagase S; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
Clin Lung Cancer; 2015 Nov; 16(6):e213-21. PubMed ID: 25986624
[TBL] [Abstract][Full Text] [Related]
3. Highly sensitive detection of EGFR T790M mutation using colony hybridization predicts favorable prognosis of patients with lung cancer harboring activating EGFR mutation.
Fujita Y; Suda K; Kimura H; Matsumoto K; Arao T; Nagai T; Saijo N; Yatabe Y; Mitsudomi T; Nishio K
J Thorac Oncol; 2012 Nov; 7(11):1640-4. PubMed ID: 22899358
[TBL] [Abstract][Full Text] [Related]
4. Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer.
He C; Liu M; Zhou C; Zhang J; Ouyang M; Zhong N; Xu J
Int J Cancer; 2009 Nov; 125(10):2393-9. PubMed ID: 19530244
[TBL] [Abstract][Full Text] [Related]
5. Application of a highly sensitive detection system for epidermal growth factor receptor mutations in plasma DNA.
Nakamura T; Sueoka-Aragane N; Iwanaga K; Sato A; Komiya K; Kobayashi N; Hayashi S; Hosomi T; Hirai M; Sueoka E; Kimura S
J Thorac Oncol; 2012 Sep; 7(9):1369-81. PubMed ID: 22858585
[TBL] [Abstract][Full Text] [Related]
6. A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNA.
Nakamura T; Sueoka-Aragane N; Iwanaga K; Sato A; Komiya K; Abe T; Ureshino N; Hayashi S; Hosomi T; Hirai M; Sueoka E; Kimura S
J Thorac Oncol; 2011 Oct; 6(10):1639-48. PubMed ID: 21921847
[TBL] [Abstract][Full Text] [Related]
7. Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity.
Han HS; Lim SN; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Son SM; Choi SY; Lee HC; Lee OJ
J Thorac Oncol; 2012 Feb; 7(2):355-64. PubMed ID: 22157369
[TBL] [Abstract][Full Text] [Related]
8. EGFR array: uses in the detection of plasma EGFR mutations in non-small cell lung cancer patients.
Yam I; Lam DC; Chan K; Chung-Man Ho J; Ip M; Lam WK; Chan TK; Chan V
J Thorac Oncol; 2012 Jul; 7(7):1131-40. PubMed ID: 22610259
[TBL] [Abstract][Full Text] [Related]
9. Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial.
Karachaliou N; Mayo-de las Casas C; Queralt C; de Aguirre I; Melloni B; Cardenal F; Garcia-Gomez R; Massuti B; Sánchez JM; Porta R; Ponce-Aix S; Moran T; Carcereny E; Felip E; Bover I; Insa A; Reguart N; Isla D; Vergnenegre A; de Marinis F; Gervais R; Corre R; Paz-Ares L; Morales-Espinosa D; Viteri S; Drozdowskyj A; Jordana-Ariza N; Ramirez-Serrano JL; Molina-Vila MA; Rosell R;
JAMA Oncol; 2015 May; 1(2):149-57. PubMed ID: 26181014
[TBL] [Abstract][Full Text] [Related]
10. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas.
Taniguchi K; Uchida J; Nishino K; Kumagai T; Okuyama T; Okami J; Higashiyama M; Kodama K; Imamura F; Kato K
Clin Cancer Res; 2011 Dec; 17(24):7808-15. PubMed ID: 21976538
[TBL] [Abstract][Full Text] [Related]
11. Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers.
Tanaka T; Nagai Y; Miyazawa H; Koyama N; Matsuoka S; Sutani A; Huqun ; Udagawa K; Murayama Y; Nagata M; Shimizu Y; Ikebuchi K; Kanazawa M; Kobayashi K; Hagiwara K
Cancer Sci; 2007 Feb; 98(2):246-52. PubMed ID: 17233841
[TBL] [Abstract][Full Text] [Related]
12. Highly sensitive and noninvasive detection of epidermal growth factor receptor T790M mutation in non-small cell lung cancer.
He C; Zheng L; Xu Y; Liu M; Li Y; Xu J
Clin Chim Acta; 2013 Oct; 425():119-24. PubMed ID: 23886554
[TBL] [Abstract][Full Text] [Related]
13. EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study.
Hubers AJ; Heideman DA; Yatabe Y; Wood MD; Tull J; Tarón M; Molina MA; Mayo C; Bertran-Alamillo J; Herder GJ; Koning R; Sie D; Ylstra B; Meijer GA; Snijders PJ; Witte BI; Postmus PE; Smit EF; Thunnissen E
Lung Cancer; 2013 Oct; 82(1):38-43. PubMed ID: 23927883
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor mutation status in cell-free DNA supernatant of bronchial washings and brushings.
Kawahara A; Fukumitsu C; Taira T; Abe H; Takase Y; Murata K; Yamaguchi T; Azuma K; Ishii H; Takamori S; Akiba J; Hoshino T; Kage M
Cancer Cytopathol; 2015 Oct; 123(10):620-8. PubMed ID: 26235264
[TBL] [Abstract][Full Text] [Related]
15. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.
Kimura H; Kasahara K; Kawaishi M; Kunitoh H; Tamura T; Holloway B; Nishio K
Clin Cancer Res; 2006 Jul; 12(13):3915-21. PubMed ID: 16818687
[TBL] [Abstract][Full Text] [Related]
16. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
[TBL] [Abstract][Full Text] [Related]
17. Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.
Li Y; Xu H; Su S; Ye J; Chen J; Jin X; Lin Q; Zhang D; Ye C; Chen C
PLoS One; 2017; 12(8):e0183331. PubMed ID: 28829813
[TBL] [Abstract][Full Text] [Related]
18. Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients.
Zhao X; Han RB; Zhao J; Wang J; Yang F; Zhong W; Zhang L; Li LY; Wang MZ
Respiration; 2013; 85(2):119-25. PubMed ID: 22797485
[TBL] [Abstract][Full Text] [Related]
19. Novel EGFR mutation-specific antibodies for lung adenocarcinoma: highly specific but not sensitive detection of an E746_A750 deletion in exon 19 and an L858R mutation in exon 21 by immunohistochemistry.
Seo AN; Park TI; Jin Y; Sun PL; Kim H; Chang H; Chung JH
Lung Cancer; 2014 Mar; 83(3):316-23. PubMed ID: 24412618
[TBL] [Abstract][Full Text] [Related]
20. Quantitative cell-free circulating EGFR mutation concentration is correlated with tumor burden in advanced NSCLC patients.
Zhu YJ; Zhang HB; Liu YH; Zhang FL; Zhu YZ; Li Y; Bai JP; Liu LR; Qu YC; Qu X; Chen X; Li Y; Zheng GJ
Lung Cancer; 2017 Jul; 109():124-127. PubMed ID: 28577941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
